FEW unexplored subcontinents remain to the worker in experimental infections; one such is mycology. Because the experimental pathology of fungous infections has not been fully investigated, there is a tendency in clinical mycology to borrow ready-made concepts from bacterial infection. For example, cases of systemic moniliasis have been treated with anti-monilial rabbit serum, on the assumption that the possession of such antibodies would benefit the patient. Attempts have been made to produce active immunization against blastomycosis with killed vaccines, on the same assumption. This is in spite of the fact that these classical immunological concepts cannot be applied to the more complicated bacteria; one does not try to immunize against the tubercle bacillus or Treponema pallidum by such means, and one would expect that immunity mechanisms in mycoses would be more akin to those operating in tuberculosis than to those operating in typhoid.
There are several a priori reasons why one should be cautious about applying the well-tried immunity concepts of bacterial and. virus infection to fungal infection without verifying them experimentally. The first and most obvious is the much larger size of the infecting organism. When considering bacterial and virus infection, it can be assumed that the infecting agent is smaller than the smallest host cells, and that it can pass between cells, across capillary walls, and across cellular membranes such as the glomerular basement membrane Without causing any mechanical disturbance. In the case of the fungi these things cannot be assumed. T'he pathogenic yeasts have approximately the diameter of a red blood cell, and a mean volume which is slightly greater. Their very presence in the host, even considered as inert particles, raises mechanical problems by virtue of their size alone. Further, many of these organisms, such as Candida albicans, produce mycelium, and a rapidly growing proliferating yeast is a large object inside the host tissues ( Fig. 1 ). Secondly, one would expect the tough polysaccharide wall of yeast cells to protect them from damage by the aggressive mechanisms of the host. The yeasts are likely to be relatively immune to the digestive action of the host enzymes, to surface-acting antibodies, to such agents as lysozyme, and to phagocytosis.
Thirdly, because of their more complex organization, one would expect fungi to have more complex enzyme systems than bacteria. The existence of these systems, operating within a metazoan host, would raise problems for both host and invader. Again, the large fungal cell must possess very many antigens. When one considers that a salmonella, with a volume of about 1 cubic micron, contains a battery of several flagellar antigens and another battery or batteries of somatic antigens, one would expect a yeast cell, with a volume 2f5 Sedion of Pathology of about 130 cubic microns, to be very much more complex antigenically. In fact, one would expect the pathogenic yeasts to possess a variety of antigenic mechanisms, not one of which is at present as well defined as are, for example, the exotoxins of Streptococcus pyogenes. It is relevant also that skin hypersensitivity reactions to whole fungus or to extracts can often be demonstrated in fungous infection, though their significance is not understood and their occurrence is not constant.
In the present reconnaissance of the field, I am concerned largely with the problem of why some yeasts are pathogenic and others are not, and why some are more pathogenic in particular circumstances than in others. Candida albicans, for example, is often found on the skin as a commensal. It is only rarely found there as a pathogen, mostly in cases of intertrigo or paronychia. Various influences have been postulated to bring about the change from commensal to pathogen, such as antibiotic therapy, agranulocytosis, cortisone therapy. Maceration is a possible cause. Experimentally, it is difficult to implant the organism into the skin of a guinea-pig by any means short of intradermal injection. I have tried various methods and failed; for example, maceration with waterproof dressings, painting the organism on to the intact or the damaged skin, or firing it into intact or injured skin with a Heaf gun.
Intradermal injection of the living organisms into guinea-pigs and rabbits causes a selflimiting disease. An inflammatory nodule forms with central necrosis; the organism is extruded with some pus and necrotic cells, leaving a clean ulcer which gradually heals. A similar but smaller lesion is produced by formalin-killed and washed organisms, and similar lesions are produced by related species of yeasts, both living and formalin-killed. Strangely enough, killed Cryptococcus neoformans is less toxic to the skin than killed yeasts of the genus Candida.
Systemic cortisone does not have an adverse effect on the development of the intradermal lesion. In fact, the size and duration of the lesions in cortisone-treated animals are, if anything, rather less than in the untreated. If living organisms of the candida group are injected into the peritoneal cavity, again they do not cause a progressive disease, nor does cortisone treatment affect them adversely.
After intraperitoneal injection of Candida dibicans, guinea-pigs show a peritonitis in a week or so. One may find one or two abscesses on the liver, but the organisms do not invade. If the animals are left a few weeks before sacrifice, no evidence of disease is found. Other yeasts of this group cause a less marked, more transient peritoneal reaction.
The most interesting features are seen in blood stream infections. If various yeasts of the candida group are injected intravenously into rabbits in large doses, only C. albicans produces disease, the other yeasts do not. And the systemic disease so produced is fatal within a few days, in both rabbits and guinea-pigs.
The histological features of this disease have been described elsewhere (Evans and Winner, 1954) . I want to draw attention to one or two of the more striking points.
First, one is struck at necropsy by the apparent lack of involvement of the lymphoreticular system. Although the animals have died of a blood-stream infection, neither spleen nor lymph nodes are enlarged or septic. Secondly, the lesions show a large amount of yeast, but a small amount of cellular reaction (Fig. 1) . These two features are in sharp contrast to what is seen in most bacterial or viral infections, and they suggest that the immunity mechanisms of the host are not adapted to dealing with this type of infection.
In the systemic disease in rabbits, the most prominent lesions are to be seen in the kidneys (Evans and Winner, 1954) . Theclinical picture is one of gradually increasing listlessness and inactivity, oliguria, sometimes coma or convulsions, and at death the animals have a high blood urea. The immediate cause of death is uremia.
It is tempting to suggest that the urnmia is due to the mechanical presence of this large organism in the kidney, causing the renal function to diminish until it can no longer support life. Further experiments show that this is too simple a view. If animals are actively immunized by repeated injections of the living organism, they are not thereby protected from the lethal effects of the organism (Winner, 1956) . Immunization, using the word in its specialized sense, does not protect the animals at all, nor does the possession of natural agglutinins. One must remember that antibodies induced by this type of whole-cell immunization are surface-acting antibodies. Unless the lethal mechanisms of the yeast lie on the surface of the cell, and there is no reason to suppose that they do, one would not expect them to be affected by these antibodies.
Another feature of the disease is revealed by injecting graded doses of the organism into rabbits. There is a definite threshold dose, below which the animal recovers from a transient illness, but above which it dies. Of 43 animals which received 5 million organisms or more, only one survived. On the other hand, 24 animals which received less than 2 million organisms all survived. Thus the natural defences of the animal are not entirely impotent (Winner, 1956) .
This experimental disease, then, shows a number of unusual features which are probably related. They are as follows:
(1) Lack of involvement of the spleen and lymph nodes.
(2) Relatively poor cellular response seen in histological sections.
(3) Failure of agglutinating antibodies to protect against the lethal effects of the organism.
(4) Well-defined threshold dose of organism necessary to produce death. A fifth characteristic, about which at the moment I feel rather diffident, is (5) Failure of systemic cortisone to enhance the disease. The first three at least of these characteristics are points of difference between systemic moniliasis and most types of bacterial and virus infection. Considered with the histological picture, they suggest that mechanical factors play a large part in the pathogenesis of the disease, but that they are not the whole story. The mechanical action of yeast cells will not of itself cause death. One may inject massive doses of killed C. albicans into rabbits, and the animals are none the worse; not only do they not become ill, but it is extremely difficult to detect the organisms later. Large doses of living cultures of other, antigenically related, organisms, such as Candida tropicalis, C. pseudotropicalis, C. guilliermondi, C. stellatoidea, and C. parakrusei, do not cause death or any detectable illness in the animals after intravenous injection. These species are evidently unable to multiply in the rabbit tissues, whereas C. albicans possesses some specific factor enabling it to establish itself, thereby producing disease.
Henrici (1940) postulated that C. albicans produces an exotoxin. If this were true, it would explain many features of the experimental disease. Now, if C. albicans is grown in peptone water at 370 C. for a few days, some of the culture filtrates will produce erytema in guineapigs and rabbits. Heated filtrates produce the same effect, which is not seen in cortisonetreated animals. Attempts to isolate this toxic factor have not as yet succeeded. At the moment I am trying to find out whether similar factors are to be found in filtrates of other species of candida. If not, this may be part of the answer to the question of why C. albicans is pathogenic on intravenous injection but the other yeasts are not. Yet it is not the whole answer. The filtrates themselves-produce no detectable ill-effect when injected intravenously into rabbits. If formalin-killed C. albicans is suspended in culture filtrate, and injected intravenously, no ill-effects are produced. Similarly, if living cultures of the non-pathogenic yeasts are washed, suspended in C. albicans filtrate, and injected intravenously, they remain non-pathogenic.
However, these experiments are still in the early stages.
This work is assisted by a grant from the Clinical Research Subcommittee of Charing Cross Hospital. REFERENCES , W. E. D., and WINNER, H. I. (1954 ) J. Path. Bact., 67, 531. HENIucI, A. T. (1940 ) J. Bact., 39, 113. WINNER, H. I. (1956 Multiple Fungous Infections of Skin By BETTY M. PARTRIDGE, M.A.
EVANS

London
THs study deals with those multiple infections due to fungi which were encountered among the last 5,500 patients examined at the Institute of Dermatology. These had been referred to the Department of Medical Mycology after a report was received from the routine laboratory that fungus was present on direct examination of keratinous tissues. On 52 occasions two dermatophytes, or ringworm fungi, were isolated from the same patient, and in a further 27 instances a dermatophyte and some other fungus, such as Malassezia furfur, Nocardia minutissima or Candida albicans, were recovered.
In a brief survey of these cases, reference will be made to the occurrence of Trichophyton rubrum. In almost all the patients with a double dermatophyte infection, the clinical picture simulated that associated with Trichophyton rubrum infections, and this organism was isolated from over 80 % of these cases. Other ringworm organisms tend to produce rather characteristic clinical pictures of their own, generally distinguishable from what one might call the "Trichophyton rubrum syndrome". Briefly, this has an insidious onset, usually beginning with foot lesions and with later spread to the hands in nearly 50 % of cases. Nail involvement is frequent, the nails becoming thickened, discoloured and friable. With spread to the crural region, the thighs and buttocks become involved rather than the groin. Careful laboratory examination is often necessary to detect the presence of fungus.
Multiple fungous infections will be referred to either as combined or concurrent infections. A combined infection means that more than one fungus was cultured from the same lesion. A concurrent infection means that more than one fungus was grown from separate lesions on the same occasion. Combined and concurrent infections may occur simultaneously.
The first group of multiple dermatophyte infections includes those in which Trichophyton interdigitale occurred with Trichophyton rubrum. These two dermatophytes were isolated from 20 patients in all. In 8 both organisms were cultured from the same lesion, i.e. there was a combined infection; in the other 12, the infections were concurrent. Trichophyton interdigitale was isolated from the feet in all 20, although all but one patient appeared clinically to be infected by Trichophyton rubrum. In nearly all the patients, the disease had been present for several years.
Epidermophyton floccosum and Trichophyton rubrum were found together on 17 occasions, 6 times as concurrent infections, and 11 times as combined infections. As with T. interdigitale in the first group, E. floccosum was grown from the feet, usually from toe webs, of all but 2 of these patients. Clinical evidence of infection with E. floccosum was apparent in only 8 of the patients, either as interdigital maceration, or as symmetrical, scaly, erythematous eruptions of the groin. With one exception, all the patients in this group were suffering from chronic
